Shared mechanisms among probiotic taxa: implications for general probiotic claims

Current Opinion in Biotechnology

Volumn 49, Issue , 2018, Pages 207-216

  Sanders, Mary Ellen ^a   Benson, Andrew ^b   Lebeer, Sarah ^c   Merenstein, Daniel J ^d   Klaenhammer, Todd R ^e  

^a International Scientific Association for Probiotics and Prebiotics   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY;

CORE MECHANISMS; EFFECTIVE DOSE; HEALTH BENEFITS; PROBIOTIC STRAIN; PROBIOTICS; SCIENTIFIC ADVANCES; SPECIES SPECIFICS; TAXONOMIC GROUPS;

STRAIN;

FIBRONECTIN BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOTEICHOIC ACID; MUCIN; PEPTIDOGLYCAN; PILIN; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR; PREBIOTIC AGENT;

BACTERIAL COLONIZATION; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE INFECTION; CYTOKINE PRODUCTION; DRUG EFFICACY; FATTY ACID SYNTHESIS; HUMAN; IMMUNOMODULATION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS AMYLOPHILUS; LACTOBACILLUS AMYLOVORUS; LACTOBACILLUS BREVIS; LACTOBACILLUS CASEI; LACTOBACILLUS CRISPATUS; LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS; LACTOBACILLUS GALLINARUM; LACTOBACILLUS GASSERI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS JENSENII; LACTOBACILLUS JOHNSONII; LACTOBACILLUS KEFIRANOFACIENS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LISTERIA MONOCYTOGENES; NECROTIZING ENTEROCOLITIS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW; STREPTOCOCCUS THERMOPHILUS; CLASSIFICATION; DRUG LABELING; EUROPE; META ANALYSIS (TOPIC);

BIFIDOBACTERIUM; DRUG LABELING; EUROPE; HUMANS; LACTOBACILLUS; META-ANALYSIS AS TOPIC; PREBIOTICS; PROBIOTICS;

EID: 85033385348     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2017.09.007     Document Type: Review

References (68)

1. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (2014), 506–514 Important consensus by group of experts in the field on updating the 2002 FAO/WHO probiotic definition and correct use of the term. The concept of shared mechanisms dictating shared benefits at the species or higher level is developed.
2. Food and Agricultural Organization of the United Nations and World Health Organization, Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2002.
3. Hill, C., Sanders, M.E., Rethinking “probiotics”. Gut Microbes 4 (2013), 269–270 The concept of shared mechanisms dictating shared benefits at the species or higher level is proposed.
4. O'Toole, P.W., Marchesi, J.R., Hill, C., Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol, 2, 2017, 17057.
5. Corr, S.C., Li, Y., Riedel, C.U., O'Toole, P.W., Hill, C., Gahan, C.G., Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104 (2007), 7617–7621.
6. O'Shea, E.F., O'Connor, P.M., Raftis, E.J., O'Toole, P.W., Stanton, C., Cotter, P.D., Ross, R.P., Hill, C., Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius. J Bacteriol 193 (2011), 6973–6982.
7. AlFaleh, K., Anabrees, J., Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2014, CD005496.
8. O'Callaghan, A., van Sinderen, D., Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol, 7, 2016.
9. Wang, C., Shoji, H., Sato, H., Nagata, S., Ohtsuka, Y., Shimizu, T., Yamashiro, Y., Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants. J Pediatr Gastroenterol Nutr 44 (2007), 252–257.
10. Bird, A.R., Vuaran, M., Crittenden, R., Hayakawa, T., Playne, M.J., Brown, I.L., Topping, D.L., Comparative effects of a high-amylose starch and a fructooligosaccharide on fecal bifidobacteria numbers and short-chain fatty acids in pigs fed Bifidobacterium animalis. Dig Dis Sci 54 (2009), 947–954.
11. Gargari, G., Taverniti, V., Balzaretti, S., Ferrario, C., Gardana, C., Simonetti, P., Guglielmetti, S., Consumption of a Bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults. Appl Environ Microbiol 82 (2016), 5850–5859.
12. Hald, S., Schioldan, A.G., Moore, M.E., Dige, A., Laerke, H.N., Agnholt, J., Bach Knudsen, K.E., Hermansen, K., Marco, M.L., Gregersen, S., et al. Effects of arabinoxylan and resistant starch on intestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. PLOS ONE, 11, 2016, e0159223.
13. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J., Brummer, R.J., Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27 (2008), 104–119 Excellent review on the many physiological effects of butyrate and why this molecule is so important to human health.
14. Flint, H.J., Bayer, E.A., Rincon, M.T., Lamed, R., White, B.A., Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Micro 6 (2008), 121–131.
15. Scheppach, W., Effects of short chain fatty acids on gut morphology and function. Gut 35 (1994), S35–S38.
16. Falony, G., Vlachou, A., Verbrugghe, K., Vuyst, L.D., Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72 (2006), 7835–7841.
17. Cherbut, C., Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 62 (2003), 95–99.
18. Havenaar, R., Intestinal health functions of colonic microbial metabolites: a review. Beneficial Microbes 2 (2011), 103–114.
19. Cherbut, C., Aubé, A.C., Blottière, H.M., Galmiche, J.P., Effects of short-chain fatty acids on gastrointestinal motility. Scand J Gastroenterol Suppl 32 (1997), 58–61.
20. Dass, N.B., John, A.K., Bassil, A.K., Crumbley, C.W., Shehee, W.R., Maurio, F.P., Moore, G.B., Taylor, C.M., Sanger, G.J., The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation. Neurogastroenterol Motil 19 (2007), 66–74.
21. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S.I., Kuwahara, A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59:Suppl 2 (2008), 251–262.
22. Vinolo, M.A.R., Rodrigues, H.G., Nachbar, R.T., Curi, R., Regulation of inflammation by short chain fatty acids. Nutrients 3 (2011), 858–876.
23. Vinolo, M.A.R., Rodrigues, H.G., Hatanaka, E., Sato, F.T., Sampaio, S.C., Curi, R., Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 22 (2011), 849–855.
24. Park, J.S., Lee, E.J., Lee, J.C., Kim, W.K., Kim, H.S., Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: involvement of NF-κB and ERK signaling pathways. Int Immunopharmacol 7 (2007), 70–77.
25. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Di, Y., Schilter, H.C., Rolph, M.S., Mackay, F., Artis, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
26. Moreau, N.M., Martin, L.J., Toquet, C.S., Laboisse, C.L., Nguyen, P.G., Siliart, B.S., Dumon, H.J., Champ, M.M., Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br J Nutr 90 (2003), 75–85.
27. Hallert, C., Bjorck, I., Nyman, M., Pousette, A., Granno, C., Svensson, H., Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis 9 (2003), 116–121.
28. Saemann, M.D., Bohmig, G.A., Zlabinger, G.J., Short-chain fatty acids: bacterial mediators of a balanced host–microbial relationship in the human gut. Wien Klin Wochenschr 114 (2002), 289–300.
29. Kunzelmann, K., Mall, M., Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82 (2002), 245–289.
30. Scheppach, W., Christl, S.U., Bartram, H.P., Richter, F., Kasper, H., Effects of short-chain fatty acids on the inflamed colonic mucosa. Scand J Gastroenterol Suppl 222 (1997), 53–57.
31. Duar, R.M., Lin, X.B., Zheng, J., Martino, M.E., Grenier, T., Perez-Munoz, M.E., Leulier, F., Ganzle, M., Walter, J., Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiol Rev 41 (2017), S27–S48.
32. Call, E.K., Klaenhammer, T.R., Relevance and application of sortase and sortase-dependent proteins in lactic acid bacteria. Front Microbiol, 4, 2013, 73.
33. Etzold, S., Kober, O.I., Mackenzie, D.A., Tailford, L.E., Gunning, A.P., Walshaw, J., Hemmings, A.M., Juge, N., Structural basis for adaptation of lactobacilli to gastrointestinal mucus. Environ Microbiol 16 (2014), 888–903.
34. Call, E.K., Goh, Y.J., Selle, K., Klaenhammer, T.R., O'Flaherty, S., Sortase-deficient lactobacilli: effect on immunomodulation and gut retention. Microbiology 161 (2015), 311–321.
35. Lebeer, S., Claes, I., Tytgat, H.L., Verhoeven, T.L., Marien, E., von Ossowski, I., Reunanen, J., Palva, A., Vos, W.M., Keersmaecker, S.C., et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78 (2012), 185–193.
36. Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., Satokari, R., Vesterlund, S., Hendrickx, A.P., Lebeer, S., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 106 (2009), 17193–17198.
37. Foroni, E., Serafini, F., Amidani, D., Turroni, F., He, F., Bottacini, F., O'Connell Motherway, M., Viappiani, A., Zhang, Z., Rivetti, C., et al. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb Cell Fact, 10(Suppl 1), 2011, S16.
38. Tytgat, H.L., Douillard, F.P., Reunanen, J., Rasinkangas, P., Hendrickx, A.P., Laine, P.K., Paulin, L., Satokari, R., de Vos, W.M., Lactobacillus rhamnosus GG Outcompetes Enterococcus faecium via mucus-binding pili: evidence for a novel and heterospecific probiotic mechanism. Appl Environ Microbiol 82 (2016), 5756–5762.
39. Garcia, V., Reyes-Darias, J.A., Martin-Mora, D., Morel, B., Matilla, M.A., Krell, T., Identification of a chemoreceptor for C2 and C3 carboxylic acids. Appl Environ Microbiol 81 (2015), 5449–5457.
40. Tytgat, H.L., van Teijlingen, N.H., Sullan, R.M., Douillard, F.P., Rasinkangas, P., Messing, M., Reunanen, J., Satokari, R., Vanderleyden, J., Dufrene, Y.F., et al. Probiotic gut microbiota isolate interacts with dendritic cells via glycosylated heterotrimeric pili. PLOS ONE, 11, 2016, e0151824.
41. Hymes, J.P., Klaenhammer, T.R., Stuck in the middle: fibronectin-binding proteins in gram-positive bacteria. Front Microbiol, 7, 2016, 1504.
42. Johnson, B.R., Hymes, J., Sanozky-Dawes, R., Henriksen, E.D., Barrangou, R., Klaenhammer, T.R., Conserved S-layer-associated proteins revealed by exoproteomic survey of S-layer-forming lactobacilli. Appl Environ Microbiol 82 (2015), 134–145.
43. Wuyts, S., Wittouck, S., De Boeck, I., Allonsius, C.N., Pasolli, E., Segata, N., Lebeer, S., Large-scale phylogenomics of the Lactobacillus casei group highlights taxonomic inconsistencies and reveals novel clade-associated features. mSystems, 2, 2017.
44. Lebeer, S., Vanderleyden, J., De Keersmaecker, S.C., Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8 (2010), 171–184 Nice review of probiotic mechanisms of action and how probiotics fit within the microecology of the gut.
45. Colagiorgi, A., Turroni, F., Mancabelli, L., Serafini, F., Secchi, A., van Sinderen, D., Ventura, M., Insights into teichoic acid biosynthesis by Bifidobacterium bifidum PRL2010. FEMS Microbiol Lett, 362, 2015, fnv141.
46. Cario, E., Barrier-protective function of intestinal epithelial Toll-like receptor 2. Mucosal Immunol 1:Suppl 1 (2008), S62–S66.
47. Bron, P.A., Kleerebezem, M., Brummer, R.J., Cani, P.D., Mercenier, A., MacDonald, T.T., Garcia-Rodenas, C.L., Wells, J.M., Can probiotics modulate human disease by impacting intestinal barrier function?. Br J Nutr 117 (2017), 93–107.
48. Claes, I.J., Segers, M.E., Verhoeven, T.L., Dusselier, M., Sels, B.F., De Keersmaecker, S.C., Vanderleyden, J., Lebeer, S., Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact, 11, 2012, 161.
49. Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T., Hols, P., Mercenier, A., Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 102 (2005), 10321–10326.
50. Khazaie, K., Zadeh, M., Khan, M.W., Bere, P., Gounari, F., Dennis, K., Blatner, N.R., Owen, J.L., Klaenhammer, T.R., Mohamadzadeh, M., Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 109 (2012), 10462–10467.
51. Lebeer, S., Claes, I.J., Vanderleyden, J., Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol 20 (2012), 5–10.
52. Kant, R., de Vos, W.M., Palva, A., Satokari, R., Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease. J Med Microbiol 63 (2014), 293–308 This paper surveys the distribution of microbe-associated molecular patterns, specifically CpG motifs, among commensal bacteria, including probiotic species. Authors make the case that CpG motif-rich DNA, common among probiotic species, may drive the immune stimulatory effects observed in many probiotic strains.
53. Iliev, I.D., Kitazawa, H., Shimosato, T., Katoh, S., Morita, H., He, F., Hosoda, M., Saito, T., Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cell Microbiol 7 (2005), 403–414.
54. Iliev, I.D., Tohno, M., Kurosaki, D., Shimosato, T., He, F., Hosoda, M., Saito, T., Kitazawa, H., Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice. Scand J Immunol 67 (2008), 370–376.
55. von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., van Huynegem, K., Steidler, L., Hrncir, T., Perez-Martinez, G., et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11 (2012), 387–396 This paper is a nice demonstration through knockout mutants of a gene associated with a specific probiotic function in vivo. Anti-inflammatory activity was found to be associated with the production of the protease lactocepin made by Lactobacillus paracasei in a mouse model, and a strain deficient in the gene encoding this protease lost its anti-inflammatory ability.
56. Sun, Z., Harris, H.M., McCann, A., Guo, C., Argimon, S., Zhang, W., Yang, X., Jeffery, I.B., Cooney, J.C., Kagawa, T.F., et al. Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nat Commun, 6, 2015, 8322 Lactobacillusis diverse genus phenotypically and phylogenetically. This paper reports an expansive data set of mostly Lactobacillusgenome sequences, enriching available databases with 179 new type strains. This research provides the means to understand the distribution of traits and mechanisms throughout the Lactobacillusgenus.
57. Correa-Oliveira, R., Fachi, J.L., Vieira, A., Sato, F.T., Vinolo, M.A., Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol, 5, 2016, e73.
58. Li, P., Gu, Q., Yang, L., Yu, Y., Wang, Y., Characterization of extracellular vitamin B12 producing Lactobacillus plantarum strains and assessment of the probiotic potentials. Food Chem 234 (2017), 494–501.
59. Rossi, M., Amaretti, A., Raimondi, S., Folate production by probiotic bacteria. Nutrients 3 (2011), 118–134.
60. Glanville, J., King, S., Guarner, F., Hill, C., Sanders, M.E., A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutr J, 14, 2015, 16.
61. Marco, M.L., Heeney, D., Binda, S., Cifelli, C.J., Cotter, P.D., Foligne, B., Ganzle, M., Kort, R., Pasin, G., Pihlanto, A., et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol 44 (2017), 94–102.
62. EFSA Panel on Dietetic Products NaA, Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J, 8, 2010, 1763.
63. Foligne, B., Deutsch, S.M., Breton, J., Cousin, F.J., Dewulf, J., Samson, M., Pot, B., Jan, G., Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl Environ Microbiol 76 (2010), 8259–8264.
64. Ritchie, M.L., Romanuk, T.N., A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS ONE, 7, 2012, e34938.
65. Green, J.M., Barratt, M.J., Kinch, M., Gordon, J.I., Food and microbiota in the FDA regulatory framework. Science 357 (2017), 39–40.
66. Lemon, K.P., Armitage, G.C., Relman, D.A., Fischbach, M.A., Microbiota-targeted therapies: an ecological perspective. Sci Transl Med, 4, 2012, 137rv135.
67. Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74 (2013), 720–726.
68. Shanahan, F., Collins, S.M., Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin North Am 39 (2010), 721–726.